Low-GI total-nutrient meal replacement powder for intervening polycystic ovarian syndrome based on ketogenesis principle and application of low-GI total-nutrient meal replacement powder
A technology of polycystic ovary and meal replacement powder is applied in the directions of application, active ingredients of hydroxyl compounds, medical raw materials derived from fish feed, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0101] Embodiment 1 meal replacement powder
[0102] Calculated on the basis of 100KG cost meal replacement powder:
[0103] Raw coconut oil 15kg, conjugated linoleic acid glycerides 5kg, linseed oil 8kg, olive oil 8kg, fish oil 5kg, high oleic sunflower oil 5kg, soybean oil 5kg, whey protein concentrate 15kg, soybean protein isolate 8kg, Hydrolyzed fish collagen 2kg, casein 5kg, rice protein 5kg, quinoa flour 2kg, chia seeds 1kg, konjac powder 3kg, inulin 1kg, fructooligosaccharide 1kg, L-carnitine 0.5kg, glutamine 1.5kg, enzyme 1.5kg, multivitamin 0.3kg, and multivitamin 2kg According to the above formula, all ingredients are weighed and passed through an 80-mesh sieve, and the unsifted parts are crushed and re-sieved until all the ingredients are sieved. 20g per pack of finished product.
Embodiment 2
[0104] Embodiment 2 clinical trials
[0105] According to the two national standards of "General Rules for Formulas for Special Medical Purposes" (GB29922-2013) and "Good Manufacturing Practices for Formulas for Special Medical Purposes" (GB29923-2013) published by the National Health and Family Planning Commission in 2013, the prepared product in Example 1 Meal replacement powder is undergoing clinical trials for effect evaluation.
[0106] Preliminary experimental results and effect evaluation:
[0107] The tested PCOS patients underwent 8-week ketogenic meal replacement powder dietary intervention and found that the changes in related indicators before and after the intervention:
[0108] Body weight (-8.61±2.34) kg, P<0.001;
[0109] Body mass index (BMI) (-3.25±0.88) kg / m 2 , P<0.001;
[0110] Waist circumference (-8.4±3.1) cm, P<0.001;
[0111] Fasting insulin (-17.0±13.6) μg / mL, P<0.001;
[0112] 2h insulin (-82.8±177.7) μg / mL, P<0.05;
[0113] Total testosterone...
Embodiment 3
[0117] Embodiment 3 animal experiments
[0118] 1 Materials and methods
[0119] 1.1 Animal model construction and administration
[0120] The 70-day-old healthy and clean female SpraguDawley (SD) rats were selected to establish the polycystic ovary syndrome (PCOS) rat model according to the Poretsky method, and 3.0 U / d of human chorionic gonadotropin (HCG) was injected subcutaneously twice a day. From day 1 to day 10, the injection of intermediate-acting insulin started from 0.5U / d and gradually increased to 6.0U / d, and then injected at this dose every day. After 22 days, the levels of testosterone and insulin in the blood of the rats increased and the vaginal smears continued to appear angular. Cellular cells are in line with the PCOS model.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com